Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Ovarian Cancer
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Ovarian Cancer
    TopAbstracts in Ovarian Cancer 07/01/2009 - (DGNews)
    Mutation of FOXL2 in Granulosa-Cell Tumors of the Ovary - (N Engl J Med)
    Delayed Symptom Progression, Better Tolerability Found With Pegylated Liposomal Doxorubicin Plus Carboplatin for Ovarian Cancer: Presented at ASCO - (DGDispatch)
    TopAbstracts in Ovarian Cancer 06/03/2009 - (DGNews)
    TopAbstracts in Ovarian Cancer 05/06/2009 - (DGNews)

    News archive

     Recent webcasts/CME - Ovarian Cancer
    • Current Therapeutic Options and Clinical Issues in Recurrent Ovarian Cancer: Where Do We Stand?
    • Looking Ahead: Emerging Options in Treatment of Ovarian Cancer
    • Ovarian Cancer: Designed for the Primary Care Physician
      Gynecologic and Colorectal Cancer: Risks and Benefits of Contraceptive Methods

      Webcasts/CME archive

       Recent cases - Ovarian Cancer
        Choroidal Eye Metastases from (Recurrent) Primary Peritoneal Carcinoma: Case Report and Review of the Literature
        A Case of Meigs Syndrome Mimicking Metastatic Breast Carcinoma
        Uterine Tumours Resembling Ovarian Sex Cord Tumours: A Case Report
        Delayed Malignant Melanoma Recurrence Simulating Primary Ovarian Cancer
        Ruptured Ovarian Cystic Teratoma in Pregnancy with Diffuse Peritoneal Reaction Mimicking Advanced Ovarian Malignancy: A Case Report

        Cases archive
          




        my personal edition > ovarian cancer > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Evaluating Connection Between Ovulation and Ovarian Cancer Risk

        A DGReview of :"Ovulation and ovarian cancer: a comparison of two methods for calculating lifetime ovulatory cycles (United States)."
        Cancer Causes and Control

        12/17/2002
        By Anne MacLennan


        Episodes of anovulation prompted by menstrual disturbances should be evaluated separately from those resulting from pregnancy or oral contraceptive, say researchers in the United States.

        Obtaining additional details on menstrual factors that affect lifetime ovulatory cycles (LOC), particularly data on missed or irregular cycles, provides critical information on women's ovarian cancer risk, these investigators from Duke University Medical Center, Durham, North Carolina, have found.

        In this population-based study of ovarian cancer, Dr P G Moorman and colleagues from Duke's Cancer Prevention, Detection, and Control Research Program, Department of Community and Family Medicine compared the standard method for calculating LOC with a second method in which more detailed information on menstrual characteristics is obtained.

        To determine if the additional data results in stronger links with ovarian cancer, the researchers reviewed data from 232 cases and 242 controls and used unconditional logistic regression to estimate odds ratios for ovarian cancer by number of LOC.

        Average number of LOC was 29 fewer for the method in which more detailed menstrual cycle information was obtained as compared with the standard method (p < 0.0001). This difference was largely the effect of the inclusion in the second method of information about episodes missed/irregular periods.

        Links between LOC and ovarian cancer were weaker for the second method than the standard method. Further analyses indicated a reduced number of ovulatory cycles as result of menstrual irregularity was linked with increased ovarian cancer risk. This was on contrast to the protective effects observed for fewer ovulatory cycles due to pregnancy or oral contraceptive use.
        Cancer Causes Control 2002 Nov;13(9):807-11. "Ovulation and ovarian cancer: a comparison of two methods for calculating lifetime ovulatory cycles (United States)."

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send